Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)

NCT05100160 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT05100160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Withdrawn
Start date
September 15, 2021
Completion date
January 3, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, thoracic